ArticleVaccine2022

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial.

Chun-Mien Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.